Cardiac Assist Devices – Market Insights – Europe

The European cardiac assist market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. Growth will primarily be driven by the temporary VAD devices and expanding use of cardiac assist devices into an undertreated patient population.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for cardiac assist devices in Europe from 2019 through 2032.

Companies are following different strategies to succeed in the cardiac assist device market.

What different strategies are companies following?

Which companies are the major players in this space?

How are the new entrants in the market impacting the existing market players?

What is the future outlook of current and new market players?

The cardiac assist device market will be primarily driven by VAD devices.

What factors influence the growth of VAD market?

How does the market growth differ for durable and temporary VAD devices?

Why are physicians concerned about the recent recalls and lack of competition in the durable VAD market?

How does the future advancements look like in the durable and temporary VAD market

IABP systems market is expected to decline through 2032.

How does the usage of IABP systems vary across countries?

How is IABP systems market in Europe getting impacted by other technologies?

How will product recalls and safety issues identified in IABP devices affect the market?

The TAH market will be the strongest growing market through 2032.

How will the technical advancements and increased competition affect the TAH market throughout the forecast period?

What are the major barriers to TAH adoption, and how will this change going forward?

Table of contents